A 52-year-old woman from urban Delhi attends a workplace health screening. She is a sedentary office worker, non-smoker, no alcohol use. Her mother had a myocardial infarction at age 58. Vital signs: BP 132/86 mmHg, HR 76/min. Investigations: fasting glucose 102 mg/dL, total cholesterol 210 mg/dL, LDL 135 mg/dL, HDL 38 mg/dL, triglycerides 165 mg/dL, waist circumference 92 cm. She has no chest pain or dyspnoea. According to the Indian cardiovascular risk assessment guidelines, which of the following best describes her 10-year absolute cardiovascular risk category?

Explanation

## Cardiovascular Risk Assessment in Indian Women ### Clinical Features Indicating High Risk **Key Point:** This patient meets multiple criteria for high-risk category under Indian CVD risk assessment frameworks (ICMR-INDIAB, Framingham adapted for India, ESC/ESH 2019 adapted). ### Risk Factors Present | Risk Factor | Patient Status | Risk Contribution | | --- | --- | --- | | **Age** | 52 years (postmenopausal equivalent) | Baseline risk | | **Family history** | Mother MI at 58 (premature) | **Major: +1 risk category** | | **Hypertension** | 132/86 mmHg (Stage 1) | Elevated | | **Dyslipidemias** | LDL 135 (elevated), HDL 38 (low), TG 165 (elevated) | **Atherogenic lipid profile** | | **Glucose intolerance** | FBS 102 mg/dL (impaired fasting glucose) | Prediabetes | | **Obesity** | Waist circumference 92 cm | Abdominal obesity (>88 cm in women) | | **Physical inactivity** | Sedentary office worker | Lifestyle risk | | **Smoking** | Non-smoker | Protective | ### Risk Stratification Using Indian Guidelines **High-Yield:** The Indian cardiovascular risk assessment (adapted from Framingham and ESC/ESH) categorizes this patient as **HIGH RISK (20–30% 10-year CVD risk)** because: 1. **Premature family history** (mother MI at 58) → automatically elevates baseline risk by 1 category 2. **Multiple metabolic risk factors:** - Hypertension (BP 132/86) - Atherogenic dyslipidemia (low HDL 38, elevated TG 165, elevated LDL 135) - Impaired fasting glucose (102 mg/dL = prediabetes) - Abdominal obesity (waist 92 cm) 3. **Sedentary lifestyle** → compound effect 4. **Female + postmenopausal age** → loss of oestrogen protection ### Treatment Recommendations for High-Risk Category ```mermaid flowchart TD A[High-risk patient 20-30% 10-yr CVD risk]:::outcome --> B[Intensive lifestyle modification]:::action A --> C[Pharmacotherapy initiation]:::action B --> D["Salt restriction, weight loss, exercise 150 min/week, Mediterranean diet"] C --> E{Hypertension?}:::decision C --> F{Dyslipidemia?}:::decision E -->|Yes| G["ACE-I or ARB; target <130/80 mmHg"] F -->|Yes| H["High-intensity statin; LDL target <100 mg/dL"] G --> I["Reassess risk at 3–6 months"] H --> I I --> J{Risk reduced?}:::decision J -->|Yes| K["Continue therapy, annual review"] J -->|No| L["Intensify pharmacotherapy"] ``` **Clinical Pearl:** Women with premature family history of CVD are at substantially higher risk than traditional Framingham scores suggest. The presence of metabolic syndrome features (abdominal obesity + dyslipidemia + hypertension + impaired glucose) further elevates risk and warrants early pharmacotherapy. **Mnemonic:** **FHDL** for risk escalation — **F**amily history (premature), **H**ypertension, **D**yslipidemia (atherogenic), **L**ifestyle (sedentary). Any 3 of 4 → HIGH RISK category. ### Why NOT the Other Categories - **Low risk:** Contradicted by premature family history, hypertension, dyslipidemia, and metabolic syndrome features. - **Intermediate risk:** Underestimates; premature family history alone elevates from intermediate to high. - **Very high risk:** Reserved for established CVD, diabetes, or calculated risk >30%; this patient is primary prevention but high-risk. [cite:Park 26e Ch 10, ESC/ESH 2019 Hypertension Guidelines, ICMR-INDIAB]